GlioMethyl – Promotor methylation of the DUSP-4 gene as predictive parameter for gliomas
Gliomas, especially secondary glioblastomas, are affected
with hypermethylation of the promoter region of the DUSP4 gene. Further studies have shown a significant correlation between hypermethylation of DUSP4 and prolonged survival of glioblastoma patients. Similar correlation has also been observed with MGMT promoter methylation and treatment of Glioblastoma patients with alkylating agents. The present invention therefore provides a predictive epigenetic parameter for diagnosis or prognosis of gliomas and may be useful for prediction of the responsiveness to certain therapies. It further describes an improved method for the determination of the promoter methylation, which is applicable for the clinical setting. This invention provides an opportunity for the development of therapeutics for secondary glioblastomas.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Innovative 3D printed scaffolds offer new hope for bone healing
Researchers at the Institute for Bioengineering of Catalonia have developed novel 3D printed PLA-CaP scaffolds that promote blood vessel formation, ensuring better healing and regeneration of bone tissue. Bone is…
The surprising role of gut infection in Alzheimer’s disease
ASU- and Banner Alzheimer’s Institute-led study implicates link between a common virus and the disease, which travels from the gut to the brain and may be a target for antiviral…
Molecular gardening: New enzymes discovered for protein modification pruning
How deubiquitinases USP53 and USP54 cleave long polyubiquitin chains and how the former is linked to liver disease in children. Deubiquitinases (DUBs) are enzymes used by cells to trim protein…